Laila Agrawal, MD IF
@lailaagrawalmd.bsky.social
90 followers 170 following 10 posts
Medical oncologist @ Norton Cancer Institute, Louisville KY Breast cancer specialist | Sexual health after cancer | Community onc | Opinions my own
Posts Media Videos Starter Packs
lailaagrawalmd.bsky.social
Part 2⃣Studies of HRT in breast cancer coming in 🔥🔥🔥@ASCO #ASCO25!!

Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.

Fewer hot flashes 🥵, more dizziness 😵‍💫
lailaagrawalmd.bsky.social
Studies of HRT in breast cancer coming in 🔥🔥🔥 #[email protected]

🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.

Sets the stage for more studies of CE/BZA in #bcsm
lailaagrawalmd.bsky.social
VERITAC-2: Vepdegestrant showed improved progression free survival in metastatic breast cancer with ESR1 mutation 🧬

As a community oncologist, thrilled that we could offer this trial to our patients close to their homes 🏠 and now see it published today in @nejm.org and presented at #ASCO25

#bcsm
nejm.org
NEJM.org @nejm.org · May 31
In advanced breast cancer, progression-free survival was significantly longer with vepdegestrant than with fulvestrant among patients with ESR1 mutations but not in the full patient population. Full VERITAC-2 phase 3 trial results: nej.md/3ZoCL7g

#ASCO25 @ascocancer.bsky.social
lailaagrawalmd.bsky.social
Impressive overall survival benefit with the addition of inavolisib to palbo-fulvestrant in PIK3CA mutated 🧬 HR+ metastatic breast cancer in the INAVO120 study published in @nejm.org today and presented at #ASCO25

⬆️ hyperglycemia, stomatitis, GI and 👁️ side effects

#bcsm @oncoalert.bsky.social
nejm.org
NEJM.org @nejm.org · May 31
INAVO120 trial: In patients with PIK3CA-mutated advanced breast cancer, inavolisib added to palbociclib–fulvestrant led to a significant overall survival benefit, with a higher incidence of certain toxic effects than placebo. nej.md/3Zje7Vt

#ASCO25 @ascocancer.bsky.social
Reposted by Laila Agrawal, MD IF
rielymd.bsky.social
Great presentation by Dr Bauman at #ASCO25 highlights that there are many ways patients make decisions, with different priorities for their care.
Reposted by Laila Agrawal, MD IF
coffeemommy.bsky.social
Kicked off Day 2 of #ASCO25 with coffee in the Advocate Lounge
Now looking forward to this session on facilitating informed discussions around evidence-based supportive care
lailaagrawalmd.bsky.social
Congratulations! You have made an impact on so many people including me!
lailaagrawalmd.bsky.social
Fantastic chapter on digital media highlighting benefits and pitfalls of tools like social media and AI
lailaagrawalmd.bsky.social
Don’t miss our session on sexual health at #ASCO25 with @lizoriordan.bsky.social and Lawrence Jenkins.
lailaagrawalmd.bsky.social
So much great research coming out at #ASCO25 that will have a major impact for patients with #breastcancer

And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡
oncoalert.bsky.social
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸

@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
Reposted by Laila Agrawal, MD IF
oncoalert.bsky.social
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸

@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
lailaagrawalmd.bsky.social
Thank you for highlighting our 📕chapter on sexual health! @ascocancer.bsky.social @lizoriordan.bsky.social
ascocancer.bsky.social
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
Reposted by Laila Agrawal, MD IF
bettyroggenkamp.bsky.social
This 👇🏾 is for every #oncology clinician who treats #AYA.

Seriously actionable practical education and care offered in this piece. BRAVO @lailaagrawalmd.bsky.social et. al

#AYACSM #sexualhealth #lateandlongterm
ascocancer.bsky.social
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
Reposted by Laila Agrawal, MD IF
teencanceramerica.bsky.social
Hear, HEAR!

#AYACSM #lateandlongterm #cancer #sexualhealth
ascocancer.bsky.social
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
Reposted by Laila Agrawal, MD IF
realbowtiedoc.bsky.social
#supponc #pallonc @pallonccop.bsky.social #survonc
ascocancer.bsky.social
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
lailaagrawalmd.bsky.social
Excited to share that our ASCO Educational Book chapter on sexual health after cancer is now published! Grateful for the opportunity to highlight this vital, often overlooked part of survivorship care.

#CancerSurvivorship #SexualHealth
Enhancing Sexual Health for Cancer Survivors
Changes to sexual function after cancer treatment are extremely prevalent, affecting up to 90% of female patients with cancer and 40%-85% of male patients with cancer. Sexual health concerns include l...
ascopubs.org
Reposted by Laila Agrawal, MD IF
drsgraff.bsky.social
Hot tips from #ASCOAdvocacySummit #ASCOAdvocacy:

A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared.

Preach! 🙌🏻 🗣️
@ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social